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During the development of a zosteriform rash, which occurs after flank inoculation of BALB/c mice with
herpes simplex virus, clinically normal skin becomes infected via nerve endings. This is analogous to the final
step in the development of a recrudescent lesion, which may occur after reactivation of latent virus. Therefore,
the zosteriform reaction has potential as a model with which to study the modification of such a recrudescent
infection by immune processes. Using an adoptive transfer system, we confirmed that immune lymph node cells
are potent in accelerating the clearance of virus from the primary site of replication (the inoculation site). This
effect was T cell dependent. However, if injection of the same cell population was delayed until ganglionic
infection was established, the appearance of the zosteriform rash was not prevented, and the virus titer
recovered from the lower flank was not reduced. Immunoperoxidase studies showed that virus is at first highly
localized to the epidermis after it emerges from nerves. As determined by conventional histology, little cellular
infiltration was seen until clinical lesions were apparent. These observations indicate that recrudescent lesions
appear in the presence of cell populations normally associated with rapid virus clearance; cellular immune
mechanisms may be rendered ineffective owing to the lack of recruitment to the site of recrudescence until
tissue breakdown instigates an inflammatory response.
In 1923 Teague and Goodpasture (26) observed that rab-
bits injected in the midflank with herpes simplex virus (HSV)
developed a bandlike ipsilateral lesion several days later.
akin to the eruption of shingles caused by varicella-zoster
virus in humans. These authors concluded that virus trav-
elled from the inoculation site into the sensory nervous
system and then returned to the skin of the whole neuroder-
matome, resulting in the zosteriform rash.
This phenomenon has been reproduced in mice (2. 12. 25).
Although not previously appreciated, this indicates that viral
growth at any peripheral site may have a zosteriform compo-
nent superimposed on initial local replication. After flank
infection, part of this component is clearly distinguished as
being remote from the inoculation site. However, at other
sites (e.g., the ear pinna) a zosteriform component would not
be clearly recognized as distinct, for anatomical reasons.
Immunity to HSV infection in experimental animals has
been extensively investigated (18). In particular, the mouse
ear model (6) has been used to probe in detail the effects of
cellular immune mechanisms on the course of the primary
infection (8, 13, 15-17). In these studies the assumption has
been that the immune mechanisms were mediating their
effect by rapidly destroying infected epidermal or other
peripheral cells, thereby inhibiting cell-to-cell spread; a
modification of the zosteriform component of growth has not
been previously considered.
Replication of virus in skin infected via nerve endings can
be investigated separately from replication at the inoculation
site in mice infected in the flank. The importance of this
point is that this is the route by which skin is infected after
virus has reactivated in the nervous system. Although reacti-
vation precedes true recrudescence, the development of a
lesion requires infection and destruction of epidermal cells.
Therefore, in mice infected in the flank we have available a
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potential model in which immune modulation of the develop-
ment of a recrudescent lesion can be studied.
We report here our virological findings with mice infected
in the flank and demonstrate the importance of such a
system in the study of immune processes active against
primary and perhaps recrudescent HSV infection.
MATERIALS AND METHODS
Mice. Female inbred BALB/c mice raised in the Depart-
ment of Pathology animal house were used throughout. They
were infected at 6 to 8 weeks of age.
Virus. A well-characterized clone of a recent oral isolate
of HSV type 1, strain SC16 (5), was grown in BHK-21 cells
and stored in portions at -70°C until it was required.
Inoculation of mice. Each left flank was clipped and
depilated with Nair (Carter-Wallace Ltd., Folkestone, Unit-
ed Kingdom), and the mice were then lightly anesthetised
with ether. Stock virus was diluted to 5 x 106 PFU/ml, and a
10-1[l drop containing 5 x 104 PFU was placed on the skin of
the posterior flank, just lateral to the spine, over the spleen.
A total of 20 scarifications were made through the drop with
a 27-gauge hypodermic needle, giving a total scarified area of
approximately 4 mm2.
Each donor for draining lymph node cells received 105
PFU of virus in 20 pL of Glasgow modified Eagle medium
(GMEM) subcutaneously into the pinna as previously de-
scribed (6).
Removal of tissue and infectious virus assay. A 0.5-cm-
square piece of tissue encompassing the inoculation site was
removed and placed into 1 ml of HEPES (N-2-hydroxyethyl-
piperazine-N'-2-ethanesulfonic acid)-buffered GMEM. The
skin sample from the lower flank consisted of a 0.5-cm-wide
strip of skin extending between the excised inoculation site
and the anterior midline. To avoid contamination of this
specimen with inoculated skin, a 0.5-cm section adjacent to
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FIG. 1. Left flank of a mouse 5 days after infection at one point
(arrow). The zosteriform rash extends to the anterior midline.
Outlined is the extent of the sample taken for virus assay. Note the
gap left between this and the inoculation site.
the inoculation site was discarded. The instruments were
washed in methylated spirits between each manipulation.
Thoracic dorsal root ganglia supplying the dermatome of
inoculation were removed with the aid of an operating
microscope. Specimens were stored in 1 ml of HEPES-
buffered GMEM and frozen in -70°C until they were re-
quired.
To assay for the presence of infectious virus, tissue
samples were homogenized in 1 ml of GMEM containing
10% calf serum and 10% tryptose phosphate broth; 10-fold
dilutions were then tested for plaque production in BHK-21
cells (22).
Lymph node cell suspensions. Donor mice were killed 7
days after ear infection, and the nodes draining the infected
pinnae were removed. A suspension containing 108 cells per
ml in HEPES-buffered GMEM was prepared as previously
described (13). Each recipient mouse received an intrave-
nous dose of 200 dl of this preparation containing 2 x 107
cells.
T-cell depletion of lymph node cells. A total of 108 cells
were pelleted and suspended in a dilution of a rat monoclonal
anti-thy 1 antibody (designated YTS 154; a donation from H.
Waldmann, Department of Pathology, University of Cam-
bridge). The cells were incubated for 1 h on ice. Control cells
were incubated with inactivated normal serum. The cells
were again pelleted, suspended in rabbit serum, which was
used as a source of complement, and incubated for 30 min at
room temperature. Killing was determined by trypan blue
staining; 36% of the antibody-treated cells were killed,
compared with 6% nonspecific killing by complement alone.
After a wash in phosphate-buffered saline, the surviving cells
in each batch were donated to groups of five mice.
Immunoperoxidase test. The reagents used in the immuno-
peroxidase test were polyclonal sera kindly donated by
P.G.H. Gell of our laboratory. The primary antiserum was
rabbit anti-HSV, and the secondary antiserum was an anti-
allotypic rabbit anti-rabbit immunoglobulin G. Peroxidase-
rabbit anti-peroxidase conjugate was purchased from DAKO
Immunoglobulins a/s. Calf serum was obtained from Sera
Lab Ltd., Sussex, England.
Histological samples for testing were fixed in Bouin solu-
tion, processed routinely, and mounted in paraffin blocks.
Sections (thickness, 5 p.m) were cleared in xylene and
rehydrated in graded alcohol solutions. Endogenous peroxi-
dase was blocked with 0.1% hydrogen peroxide for 30 min at
room temperature; the tissue was then washed and blocked
with 20% calf serum for an additional 30 min.
The concentrations of the primary and secondary antisera
and peroxidase-rabbit anti-peroxidase conjugate were initial-
ly optimized at room temperature for incubation periods of 1
h, 10 min, and 10 min, respectively. All subsequent staining
was carried out by using these incubation times, followed by
3 min of immersion in a diaminobenzidine solution (50 mg/
100 ml).
Sensory denervation of the left flank. Access to the sensory
nerves of the flank was via a posterior midline incision
between the first thoracic and first lumbar vertebrae. Anes-
thesia and analgesia were provided by a mixture of diazepam
and fentanyl given intraperitoneally. Five nerves, which
supplied the inoculation site and most of the adjacent flank,
were sectioned in each mouse. Postoperatively, the efficacy
of the operation was checked by demonstrating a lack of
response to pinprick sensation. Control animals received a
similar operation without nerve transection.
RESULTS
Isolation of virus from the skin of the flank. A total of 15
mice were infected in the flank, and groups of 3 were killed
daily on days 1 to 5 postinfection (p.i.). A zosteriform lesion
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FIG. 2. Infectious virus titers recovered from the inoculation site
(@) and lower flank (M) on varying days postinfection. Mice were
given 5 x 104 PFU of HSV on day 0. Each point represents the
arithmetic mean of values obtained from a group of three mice. Bars
indicate ranges of values, where variation occurred.
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FIG. 3. Immunoperoxidase staining for viral antigen. (a) Skin of the lower flank. The specimen was taken on day 4 p.i., which is 24 h after
virus could first be detected at this site. Note the localization of virus to the epidermis. (b) More widespread distribution 24 h after infection at
the inoculation site.
to the lesions previously reported and illustrated in mice (2,
12, 25). The inoculation site is identified by a scab produced
during scarification of the skin. The zosteriform band ex-
tends from the posterior to the anterior midline and includes
the site at which virus was initially administered. Samples of
skin from the inoculation site and the lower flank were
separately tested for the presence of infectious virus. In all
of our experiments, inoculation of virus by scarification of
the skin produced a reliable and consistent infection, with
development of a zosteriform lesion in all mice allowed to
survive for 4 days or more.
Figure 2 shows that virus recoverd from the site of
inoculation reached a peak titer 2 days p.i. At this stage no
zosteriform spread had occurred. However, virus was de-
tectable in the lower flank by day 3 p.i. in all cases. All
surviving mice developed an interrupted bandlike lesion on
day 4 p.i., corresponding to the development of peak titers in
the lower flank skin. The lesions were confluent by day 5.
Effect of sensory neurotomy on development of the zosteri-
form lesion. We investigated the effect of sensory denerva-
tion on the spread of virus to the lower flank. A total of 10
mice had their sensory nerves to the left flank transected 6
days prior to infection; control animals received a mock
operation. After the midflank was infected, the animals were
observed daily for the development of a zosteriform erup-
tion. All 10 control animals developed visible rashes on day 4
p.i.; 8 progressed to severe lesions by day 6, and 6 of these
mice died on or before day 10, with clinical evidence of hind
limb paralysis and encephalitis. Each animal without senso-
ry innervation developed a small ulcerated lesion at the
inoculation site, but none developed zosteriform rashes, and
all survived.
Infectious virus could not be detected in the lower flank of
any of the 10 denervated mice, which were killed and tested
4 days after infection. We intend to report separately the
effect of sensory neurotomy on the local replication of virus
at the inoculation site.
Histopathological studies and localization of virus by the
immunoperoxidase technique. By immunoperoxidase stain-
ing viral antigen was demonstrated in the skin of the lower
flank on day 3 p.i., corresponding to the appearance of
infectious virus detected by the plaque assay. Figure 3a
shows that virus was at first highly localized to the epider-
mis. At this stage, hematoxylin-eosin-stained sections from
the lower flank (data not shown) showed hyperplasia and
abnormality of epidermal cells in infected regions, but little
or no inflammatory response. This contrasts with the early
cellular infiltrate that was seen at the inoculation site;
samples from mice killed at two hourly intervals after
infection showed that cellular infiltration commenced within
a few hours, in response to the trauma of inoculation and
perhaps also to the growth of virus in the dermis, which is
shown by immunoperoxidase staining in Fig. 3b.
Effect of adoptive transfer of immune lymph node cells on
the recovery of virus from the inoculation site. Recovery of
virus from the inoculation site is described above (Fig. 2). In
the same experiment a separate group of 15 infected mice
received immune cells intravenously 24 h p.i.; 7-day draining
J. VIROL.
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FIG. 4. Effect of immune cells given 24 h p.i. on the titer of
infectious virus recovered from the inoculation site. The control
animals (U) received no cells. Each test animal (0) received 2 x 107
7-day draining lymph node cells intravenously. Each point repre-
sents the arithmetic mean of values obtained from a group of three
mice. Bars indicate ranges of values, where variation occurred.
lymph node cells were used because it is known that this
population exhibits a wide range of antiviral activity in vitro
(13, 17). Figure 4 shows the effect of this adoptive transfer on
the virus titer at the inoculation site. These cells greatly
accelerated the clearance of virus from the skin, compared
with no cells. In preliminary experiments, lymph node cells
taken from uninfected mice were transferred to control
animals. However, this was found to make no difference to
the virology of the system. Subsequently, the use of these
cells was abandoned to avoid killing large numbers of normal














1 2 3 4 5
DAYS POST INFECTION
FIG. 6. Effect of 2 x 107 draining lymph node cells given 48 h p.i.
(U) on recovery of infectious virus from the lower flank, compared
with controls receiving no cells (0). Each point represents the
arithmetic mean of values obtained from a group of three mice. Bars
indicate ranges of values, where variation occurred.
and virus was undetectable by day 5 p.i. The skin of the
lower flank was assayed separately, and the results are
described below.
Effect of adoptive transfer of immune cells given 1 day p.i.
on zosteriform spread of virus. Skin samples from the lower
flanks of the mice used in the previous experiment were
assayed to determine the effect of immune cells on viral
spread through the nervous system. In addition, the sensory
ganglia were tested for the presence of infectious virus and
compared with unprotected controls (Fig. 5a). Infectious
1 2 3 4 5 1 2 3 4 5
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FIG. 5. Effect of 2 x 107 draining lymph node cells given 24 h p.i. (U) on the recovery of infectious virus from the dorsal root ganglia (a)
and the lower flank (b), compared with controls receiving no cells (0). Each point represents the arithmetic mean of values obtained from a
group of three mice. Bars indicate ranges of values, where variation occurred.
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virus was consistently detected in the sensory ganglia of the
control mice 3 days p.i., but not on day 2. However, in a
separate experiment, 10 unprotected mice were killed 48 h
p.i., and the ganglia were kept in explant culture in HEPES-
buffered GMEM for 6 days before being tested; 9 of the 10
mice were positive for virus, showing that some virus had
reached the ganglia within 48 h of infection in the majority of
animals.
Immune cells given 1 day p.i. always led to a reduction of
infectious virus in the ganglia to below the threshold of the
assay used. Hence, it is not surprising that this procedure
also eliminated zosteriform spread to the skin of sites remote
from the inoculation (Fig. Sb). Mice allowed to survive for 4
days or more did not develop rashes, and none showed any
neurological signs.
Effect of immune cells given 2 days p.i. on zosteriform
spread. Completely different results were obtained when the
adoptive transfer of cells took place 48 h after infection (Fig.
6). Two groups of 12 mice were infected, and one group
received immune cells on day 2. Three animals from each
group were killed on days 2 through 5, and the lower flank
skin was tested for the presence of infectious virus. In this
instance zosteriform spread was not prevented by the im-
mune cells, and more surprisingly the growth of virus in the
skin was not subsequently modified by the presence of these
cells. This could not be attributed to a defect in their activity,
because the cells administered were from the same pool as
the cells used in the previous experiment and were given
concurrently. Conventional histological examination of the
skin of these mice on days 3 and 4 p.i. (the first and second
days of lower flank infection) again showed a remarkable
lack of cellular infiltration, despite clear histological changes
in the epidermal cells characteristic of herpes simplex infec-
tion. Mononuclear cell infiltration appeared between days 4
and 5, when considerable destruction of the epidermis was
also present.
Effect of T-cell depletion on the function of immune cells.
Draining lymph node cells were depleted of T cells in vitro
by incubation with anti-thy 1 antibody and complement.
Control cells were incubated with normal mouse serum and
complement. The surviving cells (64% of test cells and 94%
of control cells) were transferred to recipients 1 day after
infection. The mice were killed on day 5 p.i., and the lower
flank skin was tested for the presence of infectious virus.
The log1( virus titers for the mice given cells treated with
anti-thy 1 antibody and complement were 5.8, 5.9, 5.9, 6.1,
and 6.2; the titers for the five mice given cells treated with
complement alone were all less than 1. T-cell depletion
eliminated the protective effect of the immune cells.
DISCUSSION
The emergence of virus from nerve endings and the
subsequent infection of epidermal cells, as occurs in the
zosteriform reaction, provide a powerful model with which
to study recrudescent lesions. In the system which we
describe here, virus is detected in the epidermis distant from
the inoculation site 3 days after infection, and sectioning of
the appropriate sensory nerves prevents this, thus confirm-
ing that virus returns from the nervous system to the skin of
the flank between 48 and 72 h after infection. As zosteriform
spread was not found until day 3, it follows that the potent
antiviral action of immune lymph node cells given 1 day after
infection reflects a wholly peripheral action; i.e., the cells
act directly on herpes-infected skin. That this effect is T cell
dependent is in accord with previous findings from this (8,
13) and other laboratories (11). However, data from the
present study indicate that the zosteriform reaction may be
an important component of all primary cutaneous herpes
infections and that this should be considered when mecha-
nisms of immunological protection are investigated.
The role of T cells in recovery from acute HSV infection
has been documented (3, 10-13, 15, 16, 19, 21). However,
the mechanisms by which immune cells exert their effects
are, as yet, not fully understood. It is known that macro-
phages are recruited into areas of acute viral infection by
lymphokine-releasing T cells (1). This process is a central
feature of delayed-type hypersensitivity, which has been
extensively characterized with respect to HSV and has been
shown to play an important part in the clearance of virus
from peripheral lesions during acute infection in mice (13,
14). Cell-mediated anti-HSV activity may also include a
cytotoxic T-cell component (16, 17, 20, 23), although a role
for cytotoxic cells in vivo is difficult to demonstrate (A. A.
Nash, K.-N. Leung, and P. Wildy, in B. Roizman, ed., The
Herpesviruses, vol. 4, in press).
T cells may also cooperate with B cells for the production
of anti-HSV antibodies. There have been a number of
studies on the action of antibodies in preventing the spread
of a virus to the nervous system and in protecting against
lethal infections (4, 7, 8, 12). However, such studies offer
little insight into the mechanisms limiting the appearance of
virus in the skin, such as occurs during zosteriform spread or
true recrudescence. The effect of antibody in this situation
has still to be critically evaluated, but preliminary evidence
from our laboratory indicates that the passive administration
of high-titer neutralizing antibody can interrupt zosteriform
spread at the sensory nerve-epithelial cell junction. Howev-
er, neither antibody administered at 66 h (unpublished data)
nor immune lymphoid cells transferred at 48 h after initial
infection prevented zosteriform spread; nor did the immune
cells affect the titer of virus recovered from the lower flank
during the first 3 days of infection at this site.
The reason for this apparent failure of immunity is not
clear. It could be that the transferred immune cells are
diverted to sites other than those associated with the zosteri-
form lesion, hence diluting their effectiveness. Alternatively,
immune cells may fail to recognize virus as it first appears in
the epidermis. Support for the latter possibility is found
when histological sections of the early lesion are studied.
Virus is localized to the epidermis for at least 24 h after it
emerges from the nerves, and there is little cellular infiltra-
tion until a clinical lesion occurs. Consequently, following
infection of the epidermis in recrudescence, cellular immune
mechanisms may be rendered ineffective because of lack of
recruitment, until such a time as viral cytolysis has caused a
breakdown of the epidermal basement membrane and subse-
quent dermal damage, constituting the clinical lesion. This
observation may help to explain the paradoxical occurrence
of recrudescent lesions in humans in the face of active
immunity (24).
In conclusion, we report here a mouse flank model for the
final step in the development of a recrudescent lesion (i.e.,
the infection of epidermal cells) and show its usefulness in
the investigation of immune processes that are likely to be of
value in modifying the appearance of a clinical lesion after
reactivation. It is evident that effector mechanisms that have
access to areas of primary infection are not necessarily
available to combat recurrent disease.
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